Motilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-Growth
Category: Index Fund
Launch Date: 19-11-2024
AUM:
₹ 29.14 Cr
Expense Ratio
1.11%
Benchmark
Nifty MidSmall Healthcare TRI
ISIN
INF247L01DT9
Minimum Investment
500.0
Minimum Topup
500.0
Minimum SIP Amount
500
Fund Manager
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Motilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-Growth | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
10.6191
Last change
-0.01 (-0.0678%)
Fund Size (AUM)
₹ 29.14 Cr
Performance
4.38% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error. However, there can be no assurance or guarantee that the investment objectives of the scheme will be achieved.
Fund Manager
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| FORTIS HEALTHCARE LIMITED. EQ | 9.59 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 8.77 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 6.2 |
| ALKEM LABORATORIES LIMITED EQ | 5.8 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 5.75 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 5.58 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 5.22 |
| BIOCON LIMITED EQ | 3.89 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.53 |
| Krishna Institute Of Medical Sciences Limited | 3.27 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.66 |